Skip to content

Clinical trials

Active, not recruiting Breast Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Active, not recruiting Country / region: Italy Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20132
20145
20152
20162
20175
20185
20196
20208
202117
202213
202318
20246
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting96

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca16
Eli Lilly and Company9
Hoffmann-La Roche7
Pfizer6
Istituti Clinici Scientifici Maugeri SpA5
Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
Novartis Pharmaceuticals4
MedSIR3
Seagen, a wholly owned subsidiary of Pfizer3
Alliance Foundation Trials, LLC.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms96
Neoplasm Metastasis9
Carcinoma, Non-Small-Cell Lung6
Neoplasms6
Ovarian Neoplasms5
Neoplasms by Site4
Brain Neoplasms3
Breast Diseases3
Colonic Neoplasms3
Colorectal Neoplasms3

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.